Male sexual disturbances in liver diseases: What do we know?

Journal of Endocrinological Investigation

Volumn 33, Issue 7, 2010, Pages 501-505

  Durazzo, M ^a   Premoli, A ^a   Di Bisceglie, C ^a   Bo, S ^a   Ghigo, E ^a   Manieri, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Erectile dysfunction; Liver disease; Liver therapy; Seminal parameters

Indexed keywords

ALBUMIN; ANTIVIRUS AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; DIURETIC AGENT; PEGINTERFERON; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; DISEASE ASSOCIATION; HEMOCHROMATOSIS; HEPATITIS C; HOMOZYGOSITY; HORMONAL REGULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL INDEX OF ERECTILE FUNCTION; IRON OVERLOAD; LIBIDO; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; MALE SEXUAL DYSFUNCTION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PREVALENCE; QUALITY OF LIFE; REVIEW; SEMEN ANALYSIS; SEMINAL PLASMA; SEXUAL BEHAVIOR; SEXUAL FUNCTION; VIRUS HEPATITIS; WILSON DISEASE;

EID: 77957277419     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346632     Document Type: Review

References (41)

1. NIH Consensus Conference: Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993, 270: 83-90.
2. Toda K, Miwa Y, Kuriyama S, et al. Erectile dysfunction in patients with chronic liver disease: its relevance to protein malnutrition. J Gastroenterol 2005, 40: 894-900. (Pubitemid 41511531)
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281: 537-44.
4. Parazzini F, Menchini Fabris F, Bortolotti A, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000, 37: 43-9. (Pubitemid 30072373)
5. Cornely CM, Schade RR, Van Thiel DH, Gavaler JS. Chronic advanced liver disease and impotence: cause and effect? Hepatology 1984, 4: 1227-30.
6. Jensen SB, Gluud C. Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study. Liver 1985, 5: 94-100.
7. Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991, 38: 531-4.
8. Simsek I, Asian G, Akarsu M, Koseoglu H, Esen A. Assessment of sexual functions in patients with chronic liver disease. Int J Impot Res 2005, 17: 343-5.
9. Huyghe E, Kamar N, Wagner F, et al. Erectile dysfunction in end-stage liver disease men. J Sex Med 2009, 6: 1395-401.
10. Wetterling T, Veltrup C, Driessen M, John U. Drinking pattern and alcohol-related medical disorders. Alcohol Alcohol 1999, 34: 330-6. (Pubitemid 29295160)
11. Ronis MJJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J. Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exper Res 2007, 31: 1269-85.
12. Purohit V. Can alcohol promote aromatization of androgens to estrogens? A review. Alcohol 2000, 22: 123-7.
13. Soykan A, Boztas H, Idilman R, et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res 2005, 17: 175-9. (Pubitemid 40434593)
14. Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002, 288: 698-9.
15. Danoff A, Khan O, Wan DW, et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006, 101: 1235-43.
16. Gluud C, Wantzin P, Eriksen J. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterology 1988, 95: 1582-7.
17. Van Thiel DH, Gavaler JS, Sanghvi AJIT. Recovery of sexual function in abstinent alcoholic men. Gastroenterology 1982, 84: 677-82.
18. Lonardo A, Carani C, Carulli N, Loria P. 'Endocrine NAFLD' a hormonocentric perspective of non-alcoholic fatty liver disease pathogenesis. J Hepatol 2006, 44: 1196-207.
19. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology 2005, 42: 473-80. (Pubitemid 41061101)
20. Huang JM, Huang TH, Qiu HY, et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastronterol 2003, 9: 736-40.
21. Collodel G, Baccetti B, Capitani S, Moretti E. Necrosis in human spermatozoa. I. Ultrastructural features and FISH study in semen from patients with uro-genital infections. J Submicrosc Cytol Pathol 2005, 37: 67-73.
22. Heathcote J, Cameron CH, Dane DS. Hepatitis-B antigen in saliva and semen. Lancet 1974, 1: 71-3.
23. Qian WP, Tan YQ, Chen Y, et al. Rapid quantification of semen hepatitis B virus DNA by real-time polymerase chain reaction. World J Gastroenterol 2005, 11: 5385-9.
24. Hadchouel M, Scotto J, Huret JL, et al. Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line. J Med Virol 1985, 16: 61-6.
25. Leruez-Ville M, Kunstmann JM, De Almeida M, Rouzioux C, Chaix ML. Detection of hepatitis C virus in the semen of infected men. Lancet 2000, 356: 42-3. (Pubitemid 30416996)
26. Levy R, Tardy JC, Bourlet T, et al. Transmission risk of hepatitis C virus in assisted reproductive techniques. Hum Reprod 2000, 15: 810-6.
27. Durazzo M, Premoli A, Di Bisceglie C, et al. Alterations of seminal and hormonal parameters: an extrahepatic manifestation of HCV infection? World J Gastroenterol 2006, 12: 3073-6.
28. Moretti E, Federico MG, Giannerini V, Collodel G. Sperm ultrastructure and meiotic segregation in a group of patients with chronic hepatitis B and C. Andrologia 2008, 40: 173-8. (Pubitemid 351678543)
29. Levy R, Bourlet T, Maertens A, et al. Pregnancy after safe IVF with hepatitis C virus RNA-positive sperm. Hum Reprod 2002, 17: 2650-3.
30. Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod 2005, 20: 1028-34.
31. Barton JC, Acton RT, Leiendecker-Foster C, et al; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screening. Am J Hematol 2008, 83: 126-32.
32. Tarnacka B, Rodo M, Cichy S, Cztonkowska A. Procreation ability in Wilson's disease. Acta Neurol Scand 2000, 101: 395-8.
33. Soto Alvarez J, Sacristan JA, Alsar MJ. Interferon alfa-2a-induced impotence. Ann Pharmacother 1991, 25: 1397.
34. Kraus MR, Schäfer A, Bentink T, et al. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 2005, 185: 345-52.
35. Kartal ED, Alpat SN, Ozgunes I, Usluer G. Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B. Adv Ther 2007, 24: 963-71. (Pubitemid 350274773)
36. Dove LM, Rosen RC, Ramcharran D, et al; Virahep-C Study Group. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology 2009, 137: 873-84.
37. Sorrell JH, Brown JR. Sexual functioning in patients with end-stage liver disease before and after transplantation. Liver Transpl 2006, 12: 1473-7.
38. Foresta C, Schipilliti M, Ciarleglio FA, Lenzi A, D'Amico D. Male hypogonadism in cirrhosis and after liver transplantation. J Endocrinol Invest 2008, 31: 470-8.
39. Burra P. Sexual dysfunction after liver transplantation. Liver Transpl 2009, 15: S50-6.
40. Forgue ST, Phillips DL, Bedding AW, et al. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol 2007, 63: 24-35.
41. Nolte W, Schindler CG, Figulla HR, et al. Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt. J Hepatol 2001, 34: 818-24.